Başak Bala Öven

9PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AllergyTumour immunologyWork integrated learning (incl. internships)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
The role of 68Ga-FAPi PET/CT in Staging and Restaging of Breast Cancer Subtypes with Limited 18F-FDG Uptake.

|Jan 28, 2026
Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study.

İlker Nihat Ökten, Tuba Baydaş, Mahmut Emre Yıldırım

|Feb 07, 2025
Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings.

Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay

|Aug 29, 2024
Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer.

Oğuzcan Kınıkoğlu, Bala Başak Öven, Serkan Çelik

|Jul 01, 2024
Revision of the Histopathological Examination Following 68Ga-DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis.

Nalan Alan Selçuk, Kaan Akçay, Gamze Beydağı

|May 11, 2022
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı

Pageof 2

Frequent Collaborators

3 joint publications

Levent Kabasakal

3 joint publications

Serkan Çelik

3 joint publications

Gamze Beydağı

3 joint publications

Nalan Alan Selçuk